Sbir topic 85 to support the development of target specific molecular imaging agents in combination with existing imaging modalities to detect high risk atherosclerotic plaque.
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN268201400044C
- Awardee
-
Collagen Medical LLC UEI GJLBDQT8K757
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,591,491
Award facts
- Opportunity
-
- PHS20141 Solicitation number
- PHS 2014-1 Amendment 3 Award Notice · Posted Aug 14, 2013
- Contract value 100% obligated
- $1,591,490.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 8 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Belmont, MA 02478, USA
- Research
- SBIR Program Phase I Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Other Administrative Action | -$121,561 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,499,276 | |
| Other Administrative Action | $0 | |
| Original award | $213,776 |
About this award
This is a $1,591,490.86 Firm Fixed Price SBIR Phase I contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a civilian agency, to Collagen Medical LLC, a for-profit limited liability company, to support the development of target-specific molecular imaging agents in combination with existing imaging modalities to detect high-risk atherosclerotic plaque. The contract is set aside for small businesses. Collagen Medical has previously received federal grants from the National Cancer Institute, the National Institute of Biomedical Imaging and Bioengineering, and the NHLBI to conduct research and development work in areas such as cancer, cardiovascular disease, and liver disease.
Quick answers
Who was awarded contract HHSN268201400044C?
HHSN268201400044C was awarded to Collagen Medical LLC by National Heart Lung and Blood Institute (National Institutes of Health) on September 8, 2014.
How much is contract HHSN268201400044C worth?
The government has obligated $1,591,491 on HHSN268201400044C.
Was contract HHSN268201400044C competed?
The extent of competition for HHSN268201400044C was full and open competition after exclusion of sources. The government received 8 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award